These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19499208)

  • 21. Fetuin-A gene expression, synthesis and release in primary human hepatocytes cultured in a galactosylated membrane bioreactor.
    Memoli B; De Bartolo L; Favia P; Morelli S; Lopez LC; Procino A; Barbieri G; Curcio E; Giorno L; Esposito P; Cozzolino M; Brancaccio D; Andreucci VE; d'Agostino R; Drioli E
    Biomaterials; 2007 Nov; 28(32):4836-44. PubMed ID: 17706279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cultivation of primary porcine hepatocytes in an OXY-HFB for use as a bioartificial liver device.
    Jasmund I; Langsch A; Simmoteit R; Bader A
    Biotechnol Prog; 2002; 18(4):839-46. PubMed ID: 12153319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term maintenance of human hepatocytes in oxygen-permeable membrane bioreactor.
    De Bartolo L; Salerno S; Morelli S; Giorno L; Rende M; Memoli B; Procino A; Andreucci VE; Bader A; Drioli E
    Biomaterials; 2006 Sep; 27(27):4794-803. PubMed ID: 16753210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioartificial liver support: developments in hepatocyte culture and bioreactor design.
    Riordan S; Williams R
    Br Med Bull; 1997; 53(4):730-44. PubMed ID: 9536524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in bioreactors of bioartificial livers.
    Yu CB; Pan XP; Li LJ
    Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):134-40. PubMed ID: 19357025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of membrane molecular weight cutoff on a novel bioartificial liver.
    Zhang Y; Shi XL; Han B; Gu JY; Chu XH; Xiao JQ; Ren HZ; Tan JJ; Ding YT
    Artif Organs; 2012 Jan; 36(1):86-93. PubMed ID: 21819437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of encapsulated liver cell spheroids in a fluidised-bed bioartificial liver for treatment of ischaemic acute liver failure in pigs in a translational setting.
    Selden C; Spearman CW; Kahn D; Miller M; Figaji A; Erro E; Bundy J; Massie I; Chalmers SA; Arendse H; Gautier A; Sharratt P; Fuller B; Hodgson H
    PLoS One; 2013; 8(12):e82312. PubMed ID: 24367515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intramuscular transplantation of engineered hepatic tissue constructs corrects acute and chronic liver failure in mice.
    Navarro-Alvarez N; Soto-Gutierrez A; Chen Y; Caballero-Corbalan J; Hassan W; Kobayashi S; Kondo Y; Iwamuro M; Yamamoto K; Kondo E; Tanaka N; Fox IJ; Kobayashi N
    J Hepatol; 2010 Feb; 52(2):211-9. PubMed ID: 20022655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of bioartificial and artificial liver support devices.
    Hughes RD; Williams R
    Semin Liver Dis; 1996 Nov; 16(4):435-44. PubMed ID: 9027956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perfusion enhances solute transfer into the shell of hollow fiber membrane bioreactors for bone tissue engineering.
    De Napoli IE; Catapano G
    Int J Artif Organs; 2010 Jun; 33(6):381-91. PubMed ID: 20669143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Control and realization of a novel bioartificial liver support system].
    Liu J; Li M; Yang W; Lou H; Song T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):445-9. PubMed ID: 18610639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical issues in bioartificial liver development.
    Tilles AW; Berthiaume F; Yarmush ML; Toner M
    Technol Health Care; 2002; 10(3-4):177-86. PubMed ID: 12118141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced technology for extracorporeal liver support system devices.
    Borra M; Galavotti D; Bellini C; Fumi L; Morsiani E; Bellini G
    Int J Artif Organs; 2002 Oct; 25(10):939-49. PubMed ID: 12456035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hollow fiber bioreactor: new development for the study of contrast agent transport into hepatocytes by magnetic resonance imaging.
    Planchamp C; Ivancevic MK; Pastor CM; Vallée JP; Pochon S; Terrier F; Mayer JM; Reist M
    Biotechnol Bioeng; 2004 Mar; 85(6):656-65. PubMed ID: 14966807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte hollow-fibre bioreactors: design, set-up, validation and applications.
    Planchamp C; Vu TL; Mayer JM; Reist M; Testa B
    J Pharm Pharmacol; 2003 Sep; 55(9):1181-98. PubMed ID: 14604461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of a flat membrane bioreactor as a bioartificial liver.
    De Bartolo L; Bader A
    Ann Transplant; 2001; 6(3):40-6. PubMed ID: 11899896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane-based PDMS microbioreactor for perfused 3D primary rat hepatocyte cultures.
    Ostrovidov S; Jiang J; Sakai Y; Fujii T
    Biomed Microdevices; 2004 Dec; 6(4):279-87. PubMed ID: 15548875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational fluid model incorporating liver metabolic activities in perfusion bioreactor.
    Hsu MN; Tan GD; Tania M; Birgersson E; Leo HL
    Biotechnol Bioeng; 2014 May; 111(5):885-95. PubMed ID: 24311109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced oxygen delivery to primary hepatocytes within a hollow fiber bioreactor facilitated via hemoglobin-based oxygen carriers.
    Sullivan JP; Gordon JE; Bou-Akl T; Matthew HW; Palmer AF
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(6):585-606. PubMed ID: 18097786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional Evaluation of a Bioartificial Liver Support System Using Immobilized Hepatocyte Spheroids in a Porcine Model of Acute Liver Failure.
    Lee JH; Lee DH; Lee S; Kwon CHD; Ryu JN; Noh JK; Jang IK; Park HJ; Yoon HH; Park JK; Kim YJ; Kim SK; Lee SK
    Sci Rep; 2017 Jun; 7(1):3804. PubMed ID: 28630420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.